Login / Signup

Testosterone in males with COVID-19: A 7-month cohort study.

Alessia d'ArmaMarina PontilloPaolo CapogrossoSilvia GregoriCristina CarenziAnna Maria FerraraIsaline RoweLuca BoeriAlessandro LarcherGiuseppe A RamirezCristina TresoldiMassimo LocatelliGiulio CavalliLorenzo DagnaAntonella CastagnaAlberto ZangrilloMoreno TresoldiGiovanni LandoniPatrizia Rovere-QueriniFabio CiceriFrancesco Montorsi
Published in: Andrology (2021)
Although total testosterone levels increased over time after COVID-19, more than 50% of men who recovered from the disease still had circulating testosterone levels suggestive for a condition of hypogonadism at 7-month follow-up. In as many as 10% of cases, testosterone levels even further decreased. Of clinical relevance, the higher the burden of comorbid conditions at presentation, the lower the probability of testosterone levels recovery over time.
Keyphrases
  • replacement therapy
  • coronavirus disease
  • sars cov
  • smoking cessation
  • risk factors
  • respiratory syndrome coronavirus